USPH - US Physical Therapy Inc Stock Price, Fair Value and News

106.72+0.47 (+0.44%)Market Closed

Market Summary

106.72+0.47

Market Closed

0.44%

USPH Stock Price

View Fullscreen

USPH RSI Chart

USPH Valuation

Market Cap

1.6B

Price/Earnings (Trailing)

55.69

Price/Sales (Trailing)

2.63

EV/EBITDA

19.71

Price/Free Cashflow

21.43

USPH Price/Sales (Trailing)

USPH Profitability

EBT Margin

8.13%

Return on Equity

Return on Assets

2.84%

Free Cashflow Yield

4.67%

USPH Fundamentals

USPH Revenue

Revenue (TTM)

612.0M

Rev. Growth (Yr)

4.83%

Rev. Growth (Qtr)

0.56%

USPH Earnings

Earnings (TTM)

28.9M

Earnings Growth (Yr)

8.58%

Earnings Growth (Qtr)

1.1K%

Breaking Down USPH Revenue

Last 7 days

0.3%

Last 30 days

8.8%

Last 90 days

4.9%

Trailing 12 Months

-4.9%

How does USPH drawdown profile look like?

USPH Financial Health

Current Ratio

2.16

USPH Investor Care

Dividend Yield

1.62%

Dividend/Share (TTM)

1.73

Shares Dilution (1Y)

15.35%

Diluted EPS (TTM)

1.17

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	612.0M	0	0	0
2023	569.9M	580.8M	591.2M	604.8M
2022	514.4M	528.1M	541.8M	553.1M
2021	422.6M	465.7M	482.7M	495.0M
2020	478.5M	435.9M	427.6M	423.0M
2019	461.8M	473.1M	477.2M	482.0M
2018	424.8M	435.7M	445.8M	453.9M
2017	367.2M	381.0M	395.7M	414.1M
2016	341.0M	348.1M	352.4M	356.5M
2015	312.5M	317.6M	324.0M	331.3M
2014	271.1M	282.4M	294.3M	305.1M
2013	250.6M	254.1M	257.8M	264.1M
2012	242.0M	245.5M	247.9M	249.7M
2011	217.6M	223.4M	229.7M	237.0M
2010	0	204.7M	208.0M	211.2M
2009	0	0	0	201.4M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of US Physical Therapy Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 13, 2024	trier clayton	sold	-42,800	107	-400	-
Mar 13, 2024	hendrickson carey p	sold	-193,103	107	-1,800	chief financial officer
Mar 13, 2024	binstein richard	sold	-213,100	106	-2,000	evp gen'l counsel & secretary
Mar 13, 2024	ham nancy	sold	-53,945	107	-500	-
Mar 04, 2024	kuntz edward l	sold	-260,650	104	-2,500	-
Mar 04, 2024	williams eric joseph	sold	-157,440	104	-1,500	co-chief operations officer
Mar 04, 2024	reeve graham d.	sold	-274,441	104	-2,629	coo
Feb 26, 2024	hendrickson carey p	acquired	-	-	8,100	chief financial officer
Feb 26, 2024	reeve graham d.	acquired	-	-	8,100	coo
Feb 26, 2024	binstein richard	acquired	-	-	8,100	evp gen'l counsel & secretary

Which funds bought or sold USPH recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	JANE STREET GROUP, LLC	reduced	-49.66	-253,933	397,302	-%
May 16, 2024	COMERICA BANK	reduced	-6.68	117,376	1,013,520	-%
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-5.17	219,421	1,690,570	-%
May 15, 2024	MARSHALL WACE, LLP	reduced	-41.12	-1,586,440	3,952,030	0.01%
May 15, 2024	BRYN MAWR TRUST Co	new	-	2,141,940	2,141,940	0.08%
May 15, 2024	Quarry LP	new	-	4,176	4,176	-%
May 15, 2024	MORGAN STANLEY	added	2.08	24,654,400	128,668,000	0.01%
May 15, 2024	BARCLAYS PLC	reduced	-5.07	328,000	2,510,000	-%
May 15, 2024	AMERIPRISE FINANCIAL INC	reduced	-2.04	2,937,830	18,636,900	-%
May 15, 2024	QSV Equity Investors LLC	added	0.6	304,693	1,695,650	1.63%

Are Funds Buying or Selling USPH?

Are funds buying USPH calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own USPH

No. of Funds

Unveiling US Physical Therapy Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	t. rowe price investment management, inc.	5.1%	761,260	SC 13G
Feb 13, 2024	morgan stanley	6.9%	1,039,417	SC 13G/A
Feb 13, 2024	vanguard group inc	7.09%	1,062,427	SC 13G/A
Feb 13, 2024	kayne anderson rudnick investment management llc	9.11%	1,365,766	SC 13G/A
Jan 22, 2024	blackrock inc.	15.5%	2,318,096	SC 13G/A
Feb 14, 2023	price t rowe associates inc /md/	0.2%	29,108	SC 13G/A
Feb 14, 2023	t. rowe price investment management, inc.	7.0%	915,831	SC 13G
Feb 14, 2023	kayne anderson rudnick investment management llc	11.78%	1,531,533	SC 13G/A
Feb 10, 2023	morgan stanley	5.1%	656,785	SC 13G
Feb 09, 2023	vanguard group inc	7.10%	922,576	SC 13G/A

Recent SEC filings of US Physical Therapy Inc

View All Filings

Date Filed	Form Type	Document
May 17, 2024	4	Insider Trading
May 16, 2024	144	Notice of Insider Sale Intent
May 16, 2024	4	Insider Trading
May 15, 2024	144	Notice of Insider Sale Intent
May 14, 2024	4	Insider Trading
May 14, 2024	4	Insider Trading
May 10, 2024	144	Notice of Insider Sale Intent
May 10, 2024	144	Notice of Insider Sale Intent
May 09, 2024	8-K	Current Report
May 09, 2024	8-K	Current Report

Peers (Alternatives to US Physical Therapy Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	482.9B	379.5B	9.53%	9.48%	31.44	1.27	12.96%	-25.81%
CI	96.2B	206.0B	-2.11%	32.08%	24.97	0.47	12.55%	-43.95%
HCA	84.6B	66.7B	3.80%	15.55%	15.46	1.27	9.59%	-4.59%
CVS	72.4B	360.9B	-15.92%	-16.78%	9.89	0.2	9.07%	78.49%
CNC	41.7B	155.5B	8.44%	18.66%	15.24	0.27	6.34%	84.42%
DVA	12.3B	12.3B	9.53%	38.52%	15.03	0.99	5.77%	58.74%
UHS	11.9B	14.7B	11.04%	30.82%	14.63	0.81	7.99%	19.23%
MID-CAP
CHE	8.5B	2.3B	-6.47%	5.37%	30.15	3.73	5.96%	18.29%
ACHC	6.2B	3.0B	-5.49%	-7.73%	-545.12	2.06	10.92%	-104.06%
AMEH	2.3B	1.5B	9.06%	20.53%	36.62	1.57	19.34%	40.15%
AMN	2.2B	3.5B	4.01%	-38.44%	15.49	0.64	-27.67%	-62.43%
SMALL-CAP
ADUS	1.8B	1.1B	14.53%	25.72%	27.59	1.67	11.45%	30.74%
BKD	1.3B	3.0B	6.97%	85.25%	-7.66	0.44	4.98%	4.88%
BEAT	54.5M	-	-4.17%	-6.33%	-3.61	-	-	-1.05%
AMS	22.0M	21.6M	16.05%	23.93%	39.79	1.02	9.04%	-50.63%

US Physical Therapy Inc News

Latest updates

US Physical Therapy Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	0.6%	156	155	150	151	149	141	140	141	132	130	126	127	112	117	109	84.00	113	122	117	126	116
Gross Profit	-6.9%	28.00	31.00	28.00	32.00	31.00	28.00	27.00	31.00	27.00	27.00	30.00	34.00	26.00	29.00	30.00	19.00	16.00	27.00	27.00	31.00	27.00
Costs and Expenses	2.4%	127	124	122	119	118	113	113	110	105	103	96.00	93.00	86.00	88.00	79.00	65.00	97.00	95.00	90.00	95.00	90.00
S&GA Expenses	1.3%	14.00	14.00	12.00	12.00	14.00	12.00	12.00	11.00	12.00	11.00	13.00	12.00	11.00	11.00	10.00	9.00	12.00	12.00	11.00	12.00	11.00
EBITDA Margin	0.3%	0.12*	0.12*	0.13*	0.13*	0.13*	0.14*	0.16*	0.16*	0.17*	0.17*	0.19*	0.20*	-	-	-	-	-	-	-	-	-
Interest Expenses	10.9%	2.00	2.00	3.00	3.00	1.00	4.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	-	0.00	1.00	0.00	0.00	1.00	1.00	0.00
Income Taxes	124.4%	3.00	1.00	4.00	4.00	3.00	1.00	3.00	4.00	3.00	4.00	4.00	5.00	3.00	5.00	4.00	4.00	0.00	2.00	3.00	5.00	3.00
Earnings Before Taxes	13820.8%	15.00	0.00	16.00	19.00	14.00	5.00	16.00	19.00	15.00	18.00	18.00	22.00	15.00	23.00	20.00	19.00	4.00	14.00	16.00	25.00	15.00
EBT Margin	-0.5%	0.08*	0.08*	0.09*	0.09*	0.10*	0.10*	0.13*	0.14*	0.14*	0.15*	0.16*	0.17*	-	-	-	-	-	-	-	-	-
Net Income	1126.5%	8.00	1.00	9.00	11.00	7.00	3.00	10.00	11.00	9.00	10.00	10.00	12.00	8.00	13.00	11.00	10.00	1.00	8.00	9.00	15.00	8.00
Net Income Margin	1.1%	0.05*	0.05*	0.05*	0.05*	0.05*	0.06*	0.07*	0.08*	0.08*	0.08*	0.09*	0.10*	-	-	-	-	-	-	-	-	-
Free Cashflow	-83.5%	4.00	27.00	16.00	27.00	11.00	17.00	14.00	16.00	12.00	16.00	25.00	18.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	2.0%	1,017	997	1,010	1,000	868	858	800	796	764	749	630	749	749	594	575	585	594	631	561	561	523
Current Assets	-5.2%	221	233	228	242	118	111	113	122	96.00	95.00	79.00	80.00	76.00	88.00	83.00	92.00	149	85.00	93.00	107	81.00
Cash Equivalents	-13.4%	132	153	148	161	33.00	32.00	38.00	49.00	24.00	29.00	19.00	20.00	18.00	33.00	30.00	44.00	90.00	24.00	28.00	35.00	20.00
Net PPE	0.6%	26.00	26.00	26.00	25.00	25.00	25.00	25.00	24.00	24.00	23.00	22.00	22.00	22.00	22.00	21.00	23.00	23.00	22.00	21.00	20.00	21.00
Goodwill	4.8%	534	510	523	507	501	494	450	443	444	435	374	374	360	346	337	331	331	318	317	304	293
Liabilities	0.1%	345	345	342	344	384	374	333	336	304	297	201	195	182	184	170	192	260	181	188	193	165
Current Liabilities	0.3%	103	102	82.00	86.00	91.00	85.00	81.00	85.00	89.00	83.00	82.00	75.00	91.00	93.00	93.00	87.00	71.00	61.00	63.00	57.00	69.00
LT Debt, Current	19.9%	9.00	8.00	8.00	8.00	8.00	8.00	7.00	5.00	1.00	1.00	1.00	1.00	5.00	5.00	5.00	5.00	1.00	1.00	1.00	1.00	1.00
Shareholder's Equity	1.1%	481	476	492	490	319	316	319	309	302	297	291	285	277	278	266	257	242	242	237	231	221
Retained Earnings	-0.1%	224	224	239	238	235	233	236	232	227	224	219	216	210	212	203	195	183	184	181	177	169
Additional Paid-In Capital	0.9%	284	281	279	277	112	110	109	107	105	103	102	99.00	97.00	96.00	93.00	91.00	90.00	87.00	86.00	84.00	82.00
Accumulated Depreciation	2.3%	87.00	85.00	85.00	84.00	82.00	80.00	79.00	77.00	77.00	75.00	74.00	72.00	70.00	69.00	68.00	67.00	67.00	66.00	65.00	64.00	65.00
Shares Outstanding	5.8%	15.00	14.00	14.00	13.00	13.00	13.00	13.00	13.00	13.00	13.00	13.00	13.00	-	-	-	-	-	-	-	-	-
Minority Interest	20.2%	1.00	1.00	2.00	2.00	1.00	1.00	1.00	2.00	1.00	2.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	2.00	1.00	1.00
Float	-	-	-	-	1,100	-	-	-	774	-	-	-	838	-	-	-	565	-	-	-	779	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-83.5%	4,419	26,835	16,364	27,430	11,349	17,299	13,727	15,862	11,649	15,905	24,945	17,882	17,674	25,393	26,246	31,976	16,380	15,984	17,843	15,058	13,563
Share Based Compensation	11.9%	1,997	1,785	1,859	1,786	1,806	1,802	1,802	1,814	1,846	1,587	2,875	1,754	1,651	2,592	1,936	1,503	1,886	1,723	1,704	1,830	1,728
Cashflow From Investing	-143.2%	-20,464	-8,414	-16,941	-6,979	-12,681	-43,391	-14,338	-7,596	-15,944	-79,878	-10,883	-20,172	-13,203	-28,288	-4,836	-2,156	-15,923	-6,028	-6,724	-20,611	-4,630
Cashflow From Financing	66.2%	-4,490	-13,281	-12,476	107,682	2,343	19,772	-10,047	16,077	-43.00	73,352	-15,293	4,772	-19,452	5,684	-34,836	-75,816	65,546	-14,264	-18,122	20,174	-12,063
Dividend Payments	-100.0%	-	6,445	6,445	-	-	5,331	5,331	10,659	-	4,831	4,906	9,028	-	-	-	-	-	3,832	3,832	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

USPH Income Statement

2024-03-31

UNAUDITED CONSOLIDATED STATEMENTS OF NET INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues:
Net revenue	$ 155,675	$ 148,509
Operating cost:
Salaries and related costs	93,731	86,040
Rent, supplies, contract labor and other	31,916	30,100
Provision for credit losses	1,627	1,512
Total operating cost	127,274	117,652
Gross profit	28,401	30,857
Corporate office costs	14,085	13,859
Operating income	14,316	16,998
Other income (expense):
Interest expense, debt and other	(1,968)	(2,560)
Interest income from investments	1,543	64
Change in fair value of contingent earn-out consideration	612	(698)
Change in revaluation of put-right liability	(80)	(149)
Equity in earnings of unconsolidated affiliate	271	274
Relief Funds	0	467
Other	62	0
Total other income (expense)	440	(2,602)
Income before taxes	14,756	14,396
Provision for income taxes	3,139	2,969
Net income	11,617	11,427
Less: Net income attributable to non-controlling interest:
Redeemable non-controlling interest - temporary equity	(2,227)	(2,720)
Non-controlling interest - permanent equity	(1,344)	(1,297)
Net income attributable to non-controlling interest	(3,571)	(4,017)
Net income attributable to USPH shareholders	$ 8,046	$ 7,410
Basic earnings per share attributable to USPH shareholders (in dollars per share)	$ 0.46	$ 0.58
Diluted earnings per share attributable to USPH shareholders (in dollars per share)	$ 0.46	$ 0.58
Shares used in computation - basic (in shares)	15,017	13,025
Shares used in computation - diluted (in shares)	15,017	13,025
Dividends declared per common share (in dollars per share)	$ 0.44	$ 0.43
Net Patient Revenue [Member]
Revenues:
Net revenue	$ 131,075	$ 126,581
Other Revenue [Member]
Revenues:
Net revenue	$ 24,600	$ 21,928

USPH Balance Sheet

2024-03-31

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 132,290	$ 152,825
Patient accounts receivable, less provision for credit losses of $2,936 and $2,736, respectively	55,363	51,866
Accounts receivable - other	21,774	17,854
Other current assets	11,715	10,830
Total current assets	221,142	233,375
Fixed assets:
Furniture and equipment	65,550	63,982
Leasehold improvements	47,458	46,941
Fixed assets, gross	113,008	110,923
Less accumulated depreciation and amortization	(86,757)	(84,821)
Fixed assets, net	26,251	26,102
Operating lease right-of-use assets	102,113	103,431
Investment in unconsolidated affiliate	12,160	12,256
Goodwill	534,271	509,571
Other identifiable intangible assets, net	116,888	109,682
Other assets	4,431	2,821
Total assets	1,017,256	997,238
Current liabilities:
Accounts payable - trade	4,866	3,898
Accrued expenses	53,749	55,344
Current portion of operating lease liabilities	34,699	35,252
Current portion of term loan and notes payable	9,222	7,691
Total current liabilities	102,536	102,185
Notes payable, net of current portion	804	1,289
Term loan, net of current portion and deferred financing costs	135,945	137,702
Deferred taxes	27,337	24,815
Operating lease liabilities, net of current portion	75,680	76,653
Other long-term liabilities	2,988	2,356
Total liabilities	345,290	345,000
Redeemable non-controlling interest - temporary equity	190,733	174,828
Commitments and Contingencies
U.S. Physical Therapy, Inc. ("USPH") shareholders' equity:
Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding	0	0
Common stock, $.01 par value, 20,000,000 shares authorized, 17,282,822 and 17,202,291 shares issued, respectively	172	172
Additional paid-in capital	283,546	281,096
Accumulated other comprehensive gain	4,108	2,782
Retained earnings	223,573	223,772
Treasury stock at cost, 2,214,737 shares	(31,628)	(31,628)
Total USPH shareholders' equity	479,771	476,194
Non-controlling interest - permanent equity	1,462	1,216
Total USPH shareholders' equity and non-controlling interest - permanent equity	481,233	477,410
Total liabilities, redeemable non-controlling interest, USPH shareholders' equity and non-controlling interest - permanent equity	$ 1,017,256	$ 997,238

About US Physical Therapy Inc

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. The company was founded in 1990 and is based in Houston, Texas.

CEO	Mr. Christopher J. Reading
WEBSITE	usph.com
INDUSTRY	Healthcare Plans
EMPLOYEES	3570

US Physical Therapy Inc Frequently Asked Questions

What is the ticker symbol for US Physical Therapy Inc? What does USPH stand for in stocks?

USPH is the stock ticker symbol of US Physical Therapy Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of US Physical Therapy Inc (USPH)?

As of Fri May 17 2024, market cap of US Physical Therapy Inc is 1.61 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of USPH stock?

You can check USPH's fair value in chart for subscribers.

What is the fair value of USPH stock?

You can check USPH's fair value in chart for subscribers. The fair value of US Physical Therapy Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of US Physical Therapy Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for USPH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is US Physical Therapy Inc a good stock to buy?

The fair value guage provides a quick view whether USPH is over valued or under valued. Whether US Physical Therapy Inc is cheap or expensive depends on the assumptions which impact US Physical Therapy Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for USPH.

What is US Physical Therapy Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, USPH's PE ratio (Price to Earnings) is 55.69 and Price to Sales (PS) ratio is 2.63. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. USPH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on US Physical Therapy Inc's stock?

In the past 10 years, US Physical Therapy Inc has provided 0.14 (multiply by 100 for percentage) rate of return.